BCL11B and Global developmental delay: Lessel et al. (2018) reported 13 individuals harboring heterozygous mutations in BCL11B, and all analyzed individuals showed ID, developmental delay and the impairment of T‐cell development, but none displayed obvious clinical signs of immune deficiency.